PRG-2302
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PRG-2302, covering 2024-10-26 to 2024-10-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of PRG-2302 for Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia Disease. [EARLY_Phase 1]